Form 4 for NMRA Neumora Therapeutics, Inc.
Accepted 2024-12-27 00:00:00 ET · period of report 2024-12-27 · accession 0001610717-24-000555 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-12-27 | 2024-12-27 | NMRA | BERNS PAUL L | Dir | G - Gift | $0.00 | -399.3K | 7.55M | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-27 | G | D | 133,097 | $0.00 | 7,685,069 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-27 | G | D | 133,097 | $0.00 | 7,418,875 | D | — | — | |
| 3 | Common | Common Stock | 2024-12-27 | G | D | 133,097 | $0.00 | 7,551,972 | D | — | — |